A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers

Triple negative breast cancer (TNBC) represent 15% of breast cancers. Histoclinical features and marketed prognostic gene expression signatures (GES) failed to identify good- and poor-prognosis patients. Tyrosine kinases (TK) represent potential prognostic and/or therapeutic targets for TNBC. We sou...

Full description

Bibliographic Details
Main Authors: Alexandre de Nonneville, Pascal Finetti, José Adelaide, Éric Lambaudie, Patrice Viens, Anthony Gonçalves, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Cancers
Subjects:
triple negative breast cancer
tyrosine kinase
gene expression signature
prognosis
Online Access:https://www.mdpi.com/2072-6694/11/8/1158

Internet

https://www.mdpi.com/2072-6694/11/8/1158

Similar Items